Albemarle Corp

Basic Materials · Specialty Chemicals

109.70$ +1.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Albemarle Corp (ALB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,743 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ALB
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	654	697	722	737	755	858	822	854	778	922	832	885	880	993	739	764	747	879	829	774	831	894	1,128	1,480	2,092	2,621	2,580	2,370	2,311	2,356	1,361	1,430	1,355	1,232	1,077	1,330	1,308	1,428	1,429	1,743	5,908
Cost of Revenue	415	456	458	463	477	549	516	542	496	600	549	559	570	653	496	531	493	614	566	525	581	647	681	899	1,048	1,620	1,306	1,812	2,253	3,047	1,325	1,441	1,459	1,094	922	1,133	1,190	1,225	928	1,153	4,496
Gross Profit	239	241	264	274	277	308	306	312	281	321	283	326	310	340	243	233	254	265	264	248	249	247	446	581	1,044	1,001	1,275	558	58	-691	36	-11	-104	138	154	197	118	203	501	590	1,412
Research & Development	21	19	24	17	22	21	21	16	17	16	15	13	16	14	16	14	14	15	15	14	13	12	16	17	18	20	20	21	21	23	24	21	22	20	14	12	13	12	9.2	3.7	38
Selling, General & Administrative	86	125	108	116	106	109	101	124	100	121	113	127	108	185	102	107	96	430	93	112	103	123	113	129	134	148	154	397	174	194	195	169	154	136	124	132	139	156	137	126	558
Total Operating Expenses	107	145	127	129	124	125	121	134	113	132	123	135	120	194	113	114	107	132	100	129	114	116	119	140	151	168	167	185	182	203	180	181	176	154	137	143	148	154	267	137	707
Operating Income	132	96	137	145	153	183	185	178	168	189	160	191	190	145	129	119	147	134	164	120	135	131	327	441	893	833	1,108	373	-125	-894	-144	-191	-280	-16	18	54	-30	48	234	453	704
Interest Expense	16	18	69	15	16	16	14	13	13	13	13	12	11	22	17	18	19	19	44	7.2	5.1	5.3	28	41	30	24	27	26	29	34	38	35	48	45	49	50	51	58	33	31	173
Pre-Tax Income	112	70	53	137	149	171	159	391	177	157	189	205	197	101	142	119	148	92	140	553	-489	25	362	530	1,128	863	1,554	719	312	-484	13	-207	-950	96	45	69	-179	-244	254	442	273
Income Tax Expense	12	35	12	23	18	378	20	80	33	11	38	30	25	-5.1	18	15	31	-10	22	107	-115	15	81	89	197	24	277	43	-8.6	119	-3.7	-31	111	11	-4.0	34	-31	157	22	-58	91
Net Income	128	602	51	103	119	-218	132	302	130	130	134	154	155	90	107	86	98	85	96	425	-393	-3.8	253	407	897	839	1,239	650	303	-618	2.4	-188	-1,069	75	41	23	-161	-414	319	480	224
EBITDA	211	138	167	185	195	236	235	229	218	240	210	244	245	202	183	177	205	196	226	622	-422	99	459	642	1,236	887	1,670	838	447	-304	178	-34	-739	304	258	288	37	-23	445	771	1,230

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings